Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The intestinal microbial community, often referred to as the gut microbiota or gut microbiome, is a complex and dynamic ecosystem composed primarily of bacteria, but also includes archaea, viruses, fungi, and protozoa. These microorganisms inhabit the gastrointestinal tract and play essential roles in host physiology, metabolism, immunity, and overall health. Alterations in community structure/function have been linked with various diseases including metabolic disorders (obesity/diabetes), inflammatory bowel disease (IBD), neurological conditions, and cancer risk modulation.
Modulation of microbial composition and function
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal Microbial Community (None).